Immix Biopharma Ownership | Who Owns Immix Biopharma?
Immix Biopharma Ownership Summary
Immix Biopharma is owned by 8.09% institutional investors, 22.44% insiders, and 69.47% retail investors. Janus henderson group is the largest institutional shareholder, holding 12.54% of IMMX shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 4.81% of its assets in Immix Biopharma shares.
IMMX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immix Biopharma | 8.09% | 22.44% | 69.47% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Janus henderson group | 4.80M | 12.54% | $43.70M |
| Saturn v capital management | 3.69M | 9.65% | $33.65M |
| Eventide asset management | 2.55M | 6.66% | $23.22M |
| Millennium management | 1.75M | 4.57% | $15.94M |
| Marshall wace, llp | 1.64M | 4.29% | $14.95M |
| Vanguard group | 1.10M | 3.43% | $5.73M |
| Logos global management lp | 1.23M | 3.20% | $11.16M |
| Bleichroeder lp | 1.00M | 2.61% | $9.11M |
| Franklin resources | 969.07K | 2.53% | $8.83M |
| Velan capital investment management lp | 740.00K | 1.93% | $6.74M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Saturn v capital management | 3.69M | 6.09% | $33.65M |
| Velan capital investment management lp | 740.00K | 4.22% | $6.74M |
| Bleichroeder lp | 1.00M | 1.57% | $9.11M |
| Blue owl capital lp | 547.55K | 1.34% | $4.99M |
| Imprint wealth | 31.25K | 1.30% | $284.67K |
| Great point partners | 350.00K | 0.73% | $3.19M |
| Logos global management lp | 1.23M | 0.56% | $11.16M |
| Eventide asset management | 2.55M | 0.38% | $23.22M |
| Institute for wealth management, llc. | 337.55K | 0.33% | $3.08M |
| Lgt fund management | 416.59K | 0.16% | $3.80M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 4.80M | 0.02% | 880.43K |
| Velan capital investment management lp | 740.00K | 4.22% | 705.00K |
| Saturn v capital management | 3.69M | 6.09% | 694.42K |
| Price t rowe associates inc /md/ | 415.00K | 0.00% | 415.00K |
| Vanguard group | 1.10M | 0.00% | 365.65K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | - | - | -1.50M |
| Aigh capital management | - | - | -1.12M |
| Cable car capital | - | - | -779.36K |
| Ameriprise financial | - | - | -452.15K |
| Blue owl capital lp | 547.55K | 1.34% | -438.69K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Price t rowe associates inc /md/ | 415.00K | 0.00% | 415.00K | $3.78M |
| Great point partners | 350.00K | 0.73% | 350.00K | $3.19M |
| Institute for wealth management, llc. | 337.55K | 0.33% | 337.55K | $3.08M |
| Vanguard fiduciary trust | 252.91K | 0.00% | 252.91K | $2.30M |
| Bridgeway capital management | 80.00K | 0.01% | 80.00K | $728.80K |
Sold Out
| Holder | Change |
|---|---|
| Northwestern mutual wealth management | -3.00 |
| Srs capital advisors | -34.00 |
| Raymond james financial | -525.00 |
| Tortoise investment management | -1.30K |
| Steward partners investment advisory | -1.49K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 25 | -63.77% | 3,096,764 | -87.30% | 8 | 0.14% | 18 | -68.42% | 3 | -57.14% |
| Dec 31, 2025 | 31 | -3.13% | 9,543,371 | 243.79% | 29 | 34.87% | 27 | 28.57% | 4 | 33.33% |
| Sep 30, 2025 | 26 | 18.18% | 1,748,673 | -18.18% | 5 | 11.48% | 16 | 77.78% | 3 | -25.00% |
| Jun 30, 2025 | 23 | 4.55% | 2,262,228 | -22.49% | 7 | 7.81% | 10 | 42.86% | 4 | -50.00% |
| Mar 31, 2025 | 1 | -95.83% | 850,000 | -70.39% | 2 | 3.01% | - | -100.00% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 2.55M | 4.81% | 2.55M |
| Vanguard Total Stock Mkt Idx Inv | 1.29M | 2.36% | - |
| Franklin Biotechnology Discv A(acc)USD | 612.03K | 1.12% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 459.74K | 0.84% | 2.76K |
| HR SICAV - Global Quant Equits - (GBP) A | 416.59K | 0.77% | - |
| Franklin Biotechnology Discovery A | 357.03K | 0.66% | - |
| Fidelity Extended Market Index | 216.62K | 0.40% | 100.87K |
| IMC US Ultra Micro Cap | 147.14K | 0.27% | - |
| Blackrock Extended Mkt Fund CF | 106.94K | 0.20% | - |
| Extended Equity Market Fund K | 91.06K | 0.17% | 35.48K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2025 | Rachman Ilya M | CEO and Chairman | Buy | $4.98K |
| Dec 10, 2025 | Morris Gabriel S | CFO | Buy | $5.07K |
| Sep 17, 2025 | Rachman Ilya M | CEO and Chairman | Buy | $5.05K |
| Sep 16, 2025 | Morris Gabriel S | CFO | Buy | $5.12K |
| Jun 18, 2025 | Rachman Ilya M | CEO and Chairman | Buy | $5.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 2 | - |
| 2025 Q3 | 2 | - |
| 2025 Q2 | 2 | - |
| 2024 Q4 | 2 | - |
| 2024 Q3 | 5 | - |
IMMX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools